Choice of dialysis modality for patients with end-stage diabetic nephropathy

doi:10.3877/cma.j.issn.2095-3216.2016.04.004

Abstract

Abstract:

Diabetic nephropathy (DN) is one of the major causes of end-stage renal disease (ESRD). Patients with end-stage DN can choose dialysis modality of either hemodialysis (HD) or peritoneal dialysis (PD), depending upon the following factors: comorbid disease, home conditions, independence and motivation of a patient, ability to tolerate volume shift, status of the vasculature and/or abdomen, risk and history of infection, and so on.

Key words: Diabetic nephropathy, End-stage renal disease, Dialysis modality

Tianjun Guan. Choice of dialysis modality for patients with end-stage diabetic nephropathy[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2016, 05(04): 159-162.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2016.04.004

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2016/V05/I04/159

References 28

[1]	Xu Y,Wang L,He J, et al. Prevalence and control of diabetes in Chinese adults[J]. JAMA, 2013, 310(9): 948-959.
[2]	Centers for Disease Control and Prevention (CDC). Incidence of end-stage renal disease attributed to diabetes among persons with diagnosed diabetes- United States and Puerto Rico, 1996-2007[J]. MMWR Morb Mortal Wkly Rep, 2010, 59(42): 1361-1366.
[3]	Hemodialysis Adequacy 2006 Work Group. Clinical practice guidelines for hemodialysis adequacy, update 2006[J]. Am J Kidney Dis, 2006, 48(Suppl 1): S2-S90.
[4]	US Renal Data System. USRDS 2014 annual data report (2014): end-stage renal disease in the United States[CD/OL]. URL
[5]	刘莉,王梅,李雪梅, 等. 北京市血液透析患者的透析时机的变迁[J]. 中国血液净化, 2014, 13(12): 855-859.
[6]	Cooper BA,Branley P,Bulfone L, et al. A randomized, controlled trial of early versus late initiation of dialysis[J]. N Engl J Med, 2010, 363(7): 609-619.
[7]	Lameire NH. The impact of residual renal function on the adequacy of peritoneal dialysis[J]. Contrib Nephrol, 1998, 124: 76-93.
[8]	van Olden RW,van Acker BA,Koomen GC, et al. Contribution of tubular anion and cation secretion to residual renal function in chronic dialysis patients[J]. Clin Nephrol, 1998, 49(3): 167-172.
[9]	Moist Lm,Vonesh EF,Gotcg F, et al. Predictors of loss of residual renal function among new dialysis patients[J]. J Am Soc Nephrol, 2000, 11(3): 556-564.
[10]	Jansen MA,Hart AA,Korevaar JC, et a1. Predictors of the rate of decline of residual renal function in incident dialysis patients[J]. Kidney Int, 2002, 62(3): 1046-1053.
[11]	Canada USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes[J]. J Am Soc Nephrol, 1996, 7(2): 198-207.
[12]	Glorieux G,Vanholder R. New uremic toxins-which solutes should be removed?[J]. Contrib Nephrol, 2011, 168: 117-128.
[13]	Saran R,Li Y,Robinson B, et al. US Renal Data System 2014 annual data report: epidemiology of kidney disease in the United States[J]. Am J Kidney Dis, 2015, 66(1 Suppl 1): S1-S305.
[14]	Hou F,Jiang J,Chen J, et a1. China collaborative study on dialysis: a multi-centers cohort study on cardiovascular diseases in patients on maintenance dialysis[J]. BMC Nephrol, 2012, 13: 94.
[15]	Morioka T,Emoto M,Tabata T, et a1. Glycemic control is a predictor of survival for diabetic patients on hemodialysis[J]. Diabetes Care, 2001, 24(5): 909-913.
[16]	Simic-Ogrizovic S,Backus G,Mayer A, et al. The influence of different glucose concentrations in haemodialysis solutions on metabolism and blood pressure stability in diabetic patients[J]. Int J Artif Organs, 2001, 24: 863-869.
[17]	Salamon K,Woods J,Paul E, et al. Peritoneal dialysis patients have higher prevalence of gastrointestinal symptoms than hemodialysis patients[J]. J Ren Nutr, 2013, 23(2): 114-118.
[18]	Wang T,Heimbürger O,Bergström J, et al. Nutritional problems in peritoneal dialysis: an overview[J]. Perit Dial Int, 1999, 19 Suppl 2: S297-S303.
[19]	Cianciaruso B,Brunori G,Kopple JD, et al. Cross-sectional comparison of malnutrition in continuous ambulatory peritoneal dialysis and hemodialysis patients[J]. Am J Kidney Dis, 1995, 26(3): 475-486.
[20]	Bossola M,Muscaritoli M,Tazza L, et al. Malnutrition in hemodialysis patients: What therapy?[J]. Am J Kidney Dis, 2005, 46(3): 371-386.
[21]	Chung S,Koh ES,Shin SJ, et al. Malnutrition in patients with chronic kidney disease[J]. Open J Intern Med, 2012, 2: 89-99.
[22]	Pulliam J,Li NC,Maddux F, et al. First-year outcomes of incident peritoneal dialysis patients in the United States[J]. Am J Kidney Dis, 2014, 64(5): 761-769.
[23]	Collins AJ,Foley RN,Herzog C, et al. US Renal Data System 2012 Annual Data Report[J]. Am J Kidney Dis, 2013, 61(1 Suppl 1): e1-e476.
[24]	Miskulin DC,Meyer KB,Athienites NV, et al. Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study[J]. Am J Kidney Dis, 2002, 39(2): 324-336.
[25]	McDonald SP,Marshall MR,Johnson DW. Polkinghorne KR. Relationship between dialysis modality and mortality[J]. J Am Soc Nephrol, 2009, 20(1): 155-163.
[26]	Yeates K,Zhu N,Vonesh E, et al. Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada[J]. Nephrol Dial Transplant, 2012, 27(9): 3568-3575.
[27]	US Renal Data System. USRDS 2009 annual data report (2009): Atlas of chronic kidney disease and end-stage renal disease in the United States[CD/OL]. URL
[28]	Ekart R,Hojs R. Obese and diabetic patients with end-stage renal disease: Peritoneal dialysis or hemodialysis?[J]. Eur J Intern Med, 2016, 32: 1-6.

Please choose a citation manager

Content to export